← back to search

Yingnan Li

Harbin Medical University · CN
🔎 Find collaborators in Cancer Research · Physiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Physiology
Research interest
Research focused on Muscle hypertrophy and Downregulation and upregulation, with related work in Gene knockdown, Gene silencing, YAP1. Notable publications include 'The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214', 'YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF', and 'Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1'.
h-index
citations
308
works
9
NIH funding
primary concept
email

Recent publications

Biodegradable Microembolics with Nanografted Polyanions Enable High-Efficiency Drug Loading and Sustained Deep-Tumor Drug Penetration for Locoregional Chemoembolization Treatment
ACS Nano 2024cited by 16position: middledoi
Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1
Cell Death and Disease 2023cited by 21position: middledoi
Significance of m6A in subtype identification, immunological evolution, and therapeutic sensitivity of RA
Immunobiology 2023cited by 5position: lastdoi
Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1
Research Square 2022cited by 1position: middledoi
Suppression of Sox4 protects against myocardial ischemic injury by reduction of cardiac apoptosis in mice
Journal of Cellular Physiology 2020cited by 15position: middledoi
Metformin ameliorates cardiac conduction delay by regulating microRNA-1 in mice
European Journal of Pharmacology 2020cited by 13position: middledoi
YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF
Cell Death and Differentiation 2019cited by 98position: middledoi
Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study
Clinical Rheumatology 2018cited by 18position: middledoi
The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214
Molecular Therapy — Nucleic Acids 2017cited by 121position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hongli Shan · Ministry of Education of the People's Republic of China6 papers (2017–2023)Xuelian Li · Guangzhou University of Chinese Medicine5 papers (2017–2023)Haihai Liang · Ministry of Education of the People's Republic of China5 papers (2017–2023)Yingqi Liu · Nantong University4 papers (2017–2020)Lifang Lv · Harbin Medical University4 papers (2017–2022)Lijia Zhang · Harbin Medical University3 papers (2019–2020)Rui Yang · Hebei Medical University3 papers (2020–2023)Yuhong Zhou · Nanjing University of Chinese Medicine3 papers (2017–2020)Ruotong Li · Tianjin University of Traditional Chinese Medicine2 papers (2020–2020)Jing Zhang · University of Science and Technology of China2 papers (2022–2023)Tianyu Li · Harbin Medical University2 papers (2020–2023)Liangliang Li · Harbin Medical University2 papers (2022–2023)Na Yang · Indiana University School of Medicine2 papers (2022–2023)Yumeng Hou · Harbin Medical University2 papers (2022–2023)Yanjie Lu · Ministry of Education of the People's Republic of China2 papers (2019–2022)Weihang Ji · Harbin Medical University2 papers (2022–2023)Hongliang Jiang · Ministry of Education of the People's Republic of China1 papers (2024–2024)Ruonan Fang · Harbin Medical University1 papers (2020–2020)Zhihua Li · Nanchang University1 papers (2024–2024)Chao Li · Hebei North University1 papers (2020–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Physiology →